Archives: Speakers

Dudley Tabakin is the Founder and Chief Executive Officer at VivoSense, where he leads overall company strategy, operations, and the advancement of wearable sensor solutions in clinical research. He works closely with cross-functional teams to guide the integration of digital measures into global clinical trials and to support pharmaceutical partners in leveraging sensor-based data to inform development decisions. In his role, Dudley is actively engaged with sponsors and industry stakeholders to shape how wearable technologies are operationalized within clinical development programs, helping bridge scientific innovation with real-world implementation.

Chemical engineer that has worked at Nordson for 7 years. Worked in manufacturing for over 10 years.

Molecular and cell biologist that has worked at Nordson for 7 years. Worked in the Regulatory market space for 15+ years and has been an advocate for quality and process control.

Adil Qayyum is a Sales Leader at Whatfix, specializing in driving large-scale digital transformation within the Insurance domain. With a proven track record of navigating complex enterprise environments, Adil helps global carriers solve their most persistent challenge: the digital friction that stalls productivity and erodes software ROI.

Julien is Head of Product at Swiss Re, where he leads product for automated Life & Health underwriting solutions. With over 14 years of experience, he specialises in building and scaling complex enterprise software. Previously, Julien was working at Anorak (acquired by CLARK), where he helped build one of UK’s leading digital life insurance advice platforms, including a direct-to-consumer journey and a CRM for life insurance advisers. Prior to that, Julien held various positions in business development, project management, management consulting and software development at various firms across Asia, Europe and the US.

Emer Mulvaney is Contracts Manager and PPI Programme Manager at Cancer Trials Ireland, working across clinical trial start-up, strategic partnerships, and patient and public involvement. Originally trained as a Radiation Therapist, her background in direct patient care continues to shape her approach to research and healthcare delivery.

She is a strong advocate for compassionate, evidence-based care and believes that clear communication is central to good healthcare and meaningful research participation. Her work focuses on improving the efficiency of clinical trial set-up in Ireland, with a strong interest in how Ireland can become a more agile and responsive environment for cancer research and trial delivery.

Emer is deeply committed to embedding patient voices throughout the research process and believes that the best way to improve healthcare and research is to listen to the people who experience it directly. Through her work with patient partners, clinicians and researchers, she supports practical, meaningful approaches to PPI that create real impact.